We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$20.2B
AUM Growth
+$1.86B
Cap. Flow
-$3.14B
Cap. Flow %
-15.54%
Top 10 Hldgs %
19.26%
Holding
849
New
108
Increased
111
Reduced
300
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 11.02%
2 Financials 9.27%
3 Healthcare 8.73%
4 Communication Services 6.37%
5 Consumer Discretionary 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBEM icon
376
CALL
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$106M
$5.42M 0.03%
183,000
-805,600
-81% -$18.5M
HPQ icon
377
HP
HPQ
$24.3B
$5.42M 0.03%
263,817
-4,347
-2% -$82.4K
CUTR
378
DELISTED
Cutera, Inc.
CUTR
$5.33M 0.03%
148,779
+128,507
+634% +$4.34M
SJIU
379
DELISTED
South Jersey Industries, Inc.
SJIU
$5.19M 0.03%
100,000
EEFT icon
380
Euronet Worldwide
EEFT
$3.01B
$5.11M 0.03%
32,435
+13,615
+72% +$2.06M
ZAYO
381
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$5.09M 0.03%
+147,000
New +$5.03M
RARX
382
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$5.04M 0.02%
+107,500
New +$4.75M
EVER icon
383
EverQuote
EVER
$929M
$4.98M 0.02%
144,982
+56,292
+63% +$1.57M
CX icon
384
CALL
Cemex
CX
$17.6B
$4.87M 0.02%
1,094,600
+73,500
+7% +$280K
SMPL icon
385
Simply Good Foods
SMPL
$943M
$4.87M 0.02%
170,664
+7,904
+5% +$208K
REGN icon
386
Regeneron Pharmaceuticals
REGN
$69.9B
$4.82M 0.02%
12,831
-211
-2% -$71K
PVH icon
387
PVH
PVH
$3.87B
$4.79M 0.02%
45,586
-750
-2% -$71.6K
TWTR
388
DELISTED
Twitter, Inc.
TWTR
$4.79M 0.02%
149,339
-452,194
-75% -$14.9M
KNSL icon
389
Kinsale Capital Group
KNSL
$8.24B
$4.73M 0.02%
46,550
+7,825
+20% +$779K
NUE icon
390
Nucor
NUE
$56.4B
$4.73M 0.02%
84,050
-69,775
-45% -$3.81M
INSP icon
391
Inspire Medical Systems
INSP
$1.47B
$4.58M 0.02%
61,724
-21,736
-26% -$1.4M
OMCL icon
392
Omnicell
OMCL
$1.89B
$4.58M 0.02%
56,033
+7,624
+16% +$585K
BIDU icon
393
CALL
Baidu
BIDU
$35.8B
$4.56M 0.02%
36,100
+20,000
+124% +$2.27M
SYF icon
394
Synchrony
SYF
$24.5B
$4.52M 0.02%
125,426
MMP
395
DELISTED
Magellan Midstream Partners, L.P.
MMP
$4.49M 0.02%
71,380
MLCO icon
396
CALL
Melco Resorts & Entertainment
MLCO
$2.18B
$4.44M 0.02%
183,700
ULTA icon
397
Ulta Beauty
ULTA
$20.7B
$4.42M 0.02%
17,446
+26
+0.1% +$6.35K
WDC icon
398
Western Digital
WDC
$172B
$4.36M 0.02%
+90,969
New +$3.79M
TDOC icon
399
Teladoc Health
TDOC
$1.61B
$4.31M 0.02%
51,445
+23,936
+87% +$1.82M
ICE icon
400
CALL
Intercontinental Exchange
ICE
$84.1B
$4.27M 0.02%
46,100
-46,000
-50% -$4.27M

Similar funds

Calamos Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Calamos Advisors held 849 positions worth $20.2B, up 10% from $18.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Calamos Advisors withdrew a net $3.14B in Q4 2019, closing 82 positions and reducing 300 holdings. Its most notable exit was DTE Energy Company 2016 Corporate Units, an estimated $60.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $159M.

  • Calamos Advisors's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 134,761 shares worth $159M.
  • Calamos Advisors added most to Boeing in Q4 2019, an estimated $48.5M increase.
  • Calamos Advisors's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $104M.
  • Calamos Advisors fully exited DTE Energy Company 2016 Corporate Units in Q4 2019, selling an estimated $60.9M.
  • Calamos Advisors's ten largest holdings make up 19% of its $20.2B portfolio in Q4 2019.
  • Calamos Advisors opened 108 new positions and closed 82 in Q4 2019.
  • Calamos Advisors's portfolio value rose 10% quarter-over-quarter to $20.2B.

Based on Calamos Advisors's 13F filing for Q4 2019, filed 15 Jan 2020.